Summary
Colgate-Palmolive Company's 2022 10-K filing reveals a company navigating a challenging macroeconomic environment characterized by inflation and increased costs. Despite these headwinds, the company reported a 3.0% increase in Net Sales, driven by a significant 9.5% increase in selling prices, which helped offset a 2.0% decline in volume and a 4.5% negative impact from foreign exchange. Organic sales grew by 7.0%, indicating underlying brand strength. The Pet Nutrition segment, particularly Hill's Pet Nutrition, showed robust growth with a 12.0% increase in Net Sales and a 13.0% rise in organic sales, highlighting its resilience. However, the Oral, Personal, and Home Care segment experienced more modest growth and volume declines, with Europe showing flat organic sales and Asia Pacific seeing a slight decrease in net sales. The company is actively managing cost pressures through pricing actions and productivity initiatives, including the "2022 Global Productivity Initiative" aimed at reducing structural costs. Significant one-time charges, notably a $721 million pretax impairment charge related to the Filorga skin health business, impacted reported profitability. Colgate-Palmolive remains committed to shareholder returns, as evidenced by its ongoing share repurchase program and dividend increases, while also emphasizing its sustainability and DE&I strategies. The company acknowledges ongoing risks from global instability, supply chain disruptions, and evolving consumer preferences but expresses confidence in its strategy and financial position to navigate these challenges.
Financial Highlights
54 data points| Revenue | $17.97B |
| Cost of Revenue | $7.72B |
| Gross Profit | $10.25B |
| R&D Expenses | $320.00M |
| SG&A Expenses | $6.57B |
| Operating Income | $2.89B |
| Interest Expense | $172.00M |
| Net Income | $1.78B |
| EPS (Basic) | $2.13 |
| EPS (Diluted) | $2.13 |
| Shares Outstanding (Basic) | 836.40M |
| Shares Outstanding (Diluted) | 838.80M |
Key Highlights
- 1Net sales increased by 3.0% to $17,967 million, driven by a 9.5% increase in selling prices, which helped offset a 2.0% volume decline and a 4.5% negative foreign exchange impact. Organic sales grew by 7.0%.
- 2The Pet Nutrition segment (Hill's Pet Nutrition) demonstrated strong performance with a 12.0% increase in net sales and a 13.0% increase in organic sales, driven by both price increases and volume growth.
- 3The Oral, Personal, and Home Care segment saw a 1.0% increase in net sales, with organic sales growing 5.5%, but experienced volume declines across most sub-segments.
- 4Gross profit margin decreased by 260 basis points to 57.0% due to significantly higher raw and packaging material costs, which were only partially offset by price increases and cost savings initiatives.
- 5The company recorded a substantial $721 million pretax goodwill and intangible asset impairment charge related to the Filorga skin health business, impacting reported operating profit and net income.
- 6Colgate-Palmolive continued its commitment to returning capital to shareholders, repurchasing approximately $1.3 billion in shares and increasing its quarterly common stock dividend.
- 7The company is actively managing cost pressures and driving efficiencies through its "2022 Global Productivity Initiative," which aims to reduce structural costs and reallocate resources to strategic priorities.